Allergic reaction are immune responses that occur when the body overreacts to typically harmless substances known as allergens. Upon initial exposure, the immune system sensitizes to the allergen, producing specific antibodies, particularly immunoglobulin E (IgE). Upon subsequent exposure, the allergen binds to IgE on the surface of mast cells and basophils, triggering the release of inflammatory mediators like histamine. Histamine and other chemicals cause the classic symptoms of allergic reactions, including itching, swelling, redness, and, in severe cases, difficulty breathing and anaphylaxis. Allergic reactions can manifest in various forms, affecting the skin (hives, eczema), respiratory system (rhinitis, asthma), gastrointestinal tract, or the entire body. Allergies can develop at any age, and both genetic and environmental factors influence susceptibility. Public awareness, education, and ongoing research are essential for effective prevention, diagnosis, and management of allergic reactions. The severity of allergic reactions varies, ranging from mild discomfort to life-threatening emergencies. Diagnosis involves medical history, physical examination, and sometimes allergen-specific testing. Management includes allergen avoidance, medications such as antihistamines and epinephrine for severe reactions, and immunotherapy for long-term desensitization.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe